Literature DB >> 26363796

Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions.

René Große-Veldmann1, Birte Becker1, Sandra Amor2, Paul van der Valk2, Cordian Beyer1, Markus Kipp3.   

Abstract

Gray matter pathology is an important aspect of multiple sclerosis (MS) pathogenesis and disease progression. In a recent study, we were able to demonstrate that the higher myelin content in the white matter parts of the brain is an important variable in the neuroinflammatory response during demyelinating events. Whether higher white matter myelination contributes to lesion development and progression is not known. Here, we compared lesion size of intra-cortical vs. white matter MS lesions. Furthermore, dynamics of lesion development was compared in the cuprizone and lysophosphatidylcholine models. We provide clear evidence that in the human brain, white matter lesions are significantly increased in size as compared to intra-cortical gray matter lesions. In addition, studies using the cuprizone mouse model revealed that the autonomous progression of white matter lesions is more severe compared to that in the gray matter. Focal demyelination revealed that the application of equal amounts of lysophosphatidylcholine results in more severe demyelination in the white compared to the gray matter. In summary, lesion progression is most intense in myelin-rich white matter regions, irrespective of the initial lesion trigger mechanism. A better understanding of myelin debris-triggered lesion expansion will pave the way for the development of new protective strategies in the future.

Entities:  

Keywords:  Demyelination; Gray matter; Lesion expansion; Multiple sclerosis; Neurodegeneration; White matter

Mesh:

Substances:

Year:  2015        PMID: 26363796     DOI: 10.1007/s12035-015-9420-y

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  75 in total

1.  The distribution of plaques in the cerebrum in multiple sclerosis.

Authors:  B BROWNELL; J T HUGHES
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-11       Impact factor: 10.154

2.  Characterisation of microglia during de- and remyelination: can they create a repair promoting environment?

Authors:  Elke Verena Voss; Jelena Škuljec; Viktoria Gudi; Thomas Skripuletz; Refik Pul; Corinna Trebst; Martin Stangel
Journal:  Neurobiol Dis       Date:  2011-09-21       Impact factor: 5.996

3.  Soluble macrophage factors trigger apoptosis in cultured hippocampal neurons.

Authors:  M P Flavin; K Coughlin; L T Ho
Journal:  Neuroscience       Date:  1997-09       Impact factor: 3.590

4.  Nuclear structures in nerve cells in multiple sclerosis.

Authors:  C S Raine; E J Field
Journal:  Brain Res       Date:  1968-08-26       Impact factor: 3.252

5.  Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.

Authors:  Nathalie Koning; Lars Bö; Robert M Hoek; Inge Huitinga
Journal:  Ann Neurol       Date:  2007-11       Impact factor: 10.422

6.  Gray matter atrophy in multiple sclerosis: a longitudinal study.

Authors:  Elizabeth Fisher; Jar-Chi Lee; Kunio Nakamura; Richard A Rudick
Journal:  Ann Neurol       Date:  2008-09       Impact factor: 10.422

7.  Lysophosphatidyl choline-induced focal demyelination in the rabbit corpus callosum. Electron-microscopic observations.

Authors:  R E Foster; J D Kocsis; R C Malenka; S G Waxman
Journal:  J Neurol Sci       Date:  1980-11       Impact factor: 3.181

8.  Short-term cuprizone feeding induces selective amino acid deprivation with concomitant activation of an integrated stress response in oligodendrocytes.

Authors:  Johannes Goldberg; Moritz Daniel; Yasemin van Heuvel; Marion Victor; Cordian Beyer; Tim Clarner; Markus Kipp
Journal:  Cell Mol Neurobiol       Date:  2013-08-25       Impact factor: 5.046

9.  Structural brain abnormalities in multiple sclerosis patients with major depression.

Authors:  A Feinstein; P Roy; N Lobaugh; K Feinstein; P O'Connor; S Black
Journal:  Neurology       Date:  2004-02-24       Impact factor: 9.910

10.  Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.

Authors:  N De Stefano; P M Matthews; M Filippi; F Agosta; M De Luca; M L Bartolozzi; L Guidi; A Ghezzi; E Montanari; A Cifelli; A Federico; S M Smith
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

View more
  6 in total

1.  Visualization of the Breakdown of the Axonal Transport Machinery: a Comparative Ultrastructural and Immunohistochemical Approach.

Authors:  Sebastian Rühling; Franziska Kramer; Selina Schmutz; Sandra Amor; Zhan Jiangshan; Christoph Schmitz; Markus Kipp; Tanja Hochstrasser
Journal:  Mol Neurobiol       Date:  2018-09-21       Impact factor: 5.590

2.  Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.

Authors:  Stefan Esser; Larissa Göpfrich; Kai Bihler; Eugenia Kress; Stella Nyamoya; Simone C Tauber; Tim Clarner; Matthias B Stope; Thomas Pufe; Markus Kipp; Lars-Ove Brandenburg
Journal:  Mol Neurobiol       Date:  2017-12-29       Impact factor: 5.590

3.  Cuprizone-Containing Pellets Are Less Potent to Induce Consistent Demyelination in the Corpus Callosum of C57BL/6 Mice.

Authors:  Tanja Hochstrasser; Gianna Lisa Exner; Stella Nyamoya; Christoph Schmitz; Markus Kipp
Journal:  J Mol Neurosci       Date:  2017-02-25       Impact factor: 3.444

4.  Intravenous transplantation of mouse embryonic stem cells attenuates demyelination in an ICR outbred mouse model of demyelinating diseases.

Authors:  Kidsadagon Pringproa; Anucha Sathanawongs; Chananthida Khamphilai; Sarocha Sukkarinprom; Apichart Oranratnachai
Journal:  Neural Regen Res       Date:  2016-10       Impact factor: 5.135

5.  Neurodegeneration Triggers Peripheral Immune Cell Recruitment into the Forebrain.

Authors:  Miriam Scheld; Bernhard Josef Rüther; René Große-Veldmann; Kim Ohl; Klaus Tenbrock; Daniela Dreymüller; Petra Fallier-Becker; Adib Zendedel; Cordian Beyer; Tim Clarner; Markus Kipp
Journal:  J Neurosci       Date:  2016-01-27       Impact factor: 6.167

Review 6.  The Cuprizone Model: Dos and Do Nots.

Authors:  Jiangshan Zhan; Teresa Mann; Sarah Joost; Newshan Behrangi; Marcus Frank; Markus Kipp
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.